Literature DB >> 6409577

Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns.

A Szczeklik, R J Gryglewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6409577     DOI： 10.2165/00003495-198325060-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  46 in total

1.  Familial coincidence of asthma, aspirin intolerance and nasal polyposis.

Authors:  C J Falliers
Journal:  Ann Allergy       Date:  1974-02

2.  Letter: Asthma, nasal polyposis, and aspirin sensitivity.

Authors:  J C Delaney
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

3.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.

Authors:  M Samter; R F Beers
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

4.  Treatment of chronic airways obstruction with indomethacin.

Authors:  M Hume; V Eddey
Journal:  Scand J Respir Dis       Date:  1977-10

5.  Inhibition of the late asthmatic response to house dust mite by non-steroidal anti-inflammatory drugs.

Authors:  A J Fairfax
Journal:  Prostaglandins Leukot Med       Date:  1982-03

6.  Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig.

Authors:  R J Gryglewski; B Panczenko; R Korbut; L Grodzinska; A Ocetkiewicz
Journal:  Prostaglandins       Date:  1975-08

7.  Histaminemia after aspirin challenge in aspirin-sensitive asthmatics.

Authors:  M Szmidt; I Grzelewska-Rzymowska; J Rozniecki; M L Kowalski; I Rychlicka
Journal:  Agents Actions       Date:  1981-04

8.  Oral acetylsalicylic acid (aspirin) challenge in asthmatic children.

Authors:  J F Schuhl; J G Pereyra
Journal:  Clin Allergy       Date:  1979-01

Review 9.  Analgesics, allergy and asthma.

Authors:  A Szczeklik
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Idiosyncrasy to pyrazolone drugs.

Authors:  G Czerniawska-Mysik; A Szczeklik
Journal:  Allergy       Date:  1981-08       Impact factor: 13.146
View more
  13 in total

1.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  [Not Available].

Authors:  K Menges
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

3.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

4.  A review of non-steroidal anti-inflammatory drugs.

Authors:  D Rosenbloom; M A Craven
Journal:  Can Fam Physician       Date:  1983-11       Impact factor: 3.275

5.  The abnormal in vitro response to aspirin of platelets from aspirin-sensitive asthmatics is inhibited after inhalation of nedocromil sodium but not of sodium cromoglycate.

Authors:  C H Marquette; M Joseph; A B Tonnel; H Vorng; P Lassalle; A Tsicopoulos; A Capron
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

Review 6.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

7.  Bronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitisation.

Authors:  M L Kowalski; I Grzelewska-Rzymowska; M Szmidt; J Rozniecki
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

Review 8.  Crossreacting drugs and chemicals.

Authors:  Katharine M Woessner
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 9.  Ibuprofen and increased morbidity in children with asthma: fact or fiction?

Authors:  Ralph E Kauffman; Mary Lieh-Lai
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 10.  Analgesics, allergy and asthma.

Authors:  A Szczeklik
Journal:  Drugs       Date:  1986       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.